Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01404039 · ClinicalTrials.gov registry record · Phase 1
Investigating Motor Cortex Processing for Pain Modulation
A Phase 1 study, sponsored by Spaulding Rehabilitation Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 115
- Enrollment target
NCT01404039: Clinical Trial Phase 1 study, sponsored by Spaulding Rehabilitation Hospital.
NCT01404039 is a Phase 1 study that was terminated before completion, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 115 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01404039, a Phase 1 study, was terminated before completion, sponsored by Spaulding Rehabilitation Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 115 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of different types of interventions (motor learning, somatosensory learning, observation task, mental imagery and tDCS) on the perception of pain and motor cortex excitability in healthy male subjects. This is an exploratory study of healthy subjects only.
Primary Outcome
We aim to assess the effects of the intervention (ML, SL, OT and MI) on motor cortex excitability as measured by the change in motor evoked potential (using transcranial magnetic stimulation) before and after the given intervention. * For ML: MEP will be measured before and after each ML sessions in the same subject (crossover design - ML sighted/MLblind/ML control). * For SL: MEP will be measured before and after the treatment session in the each groups (parallel design - 1 session per group).
Interventions
- BEHAVIORAL Mental Imagery
- DEVICE transcranial direct current stimulation
- BEHAVIORAL Motor Learning
- BEHAVIORAL Somatosensory Learning
- BEHAVIORAL Observational Task
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
Why NCT01404039 stopped before completion
NCT01404039 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% higher).
The record links to 0 conditions, and to 5 interventions - of which Mental Imagery is the first listed.
NCT01404039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01404039 about?
NCT01404039 is a clinical study titled "Investigating Motor Cortex Processing for Pain Modulation". The purpose of this study is to investigate the effects of different types of interventions (motor learning, somatosensory learning, observation task, mental imagery and tDCS) on the perception of pain and motor cortex excitability in healthy male subjects. This is an exploratory study of healthy su...
What is the current status of trial NCT01404039?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 115 participants. The study started on 2010-09. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01404039?
The interventions under investigation include: Mental Imagery (BEHAVIORAL), transcranial direct current stimulation (DEVICE), Motor Learning (BEHAVIORAL), Somatosensory Learning (BEHAVIORAL), Observational Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT01404039?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01404039's enrollment target sits among peer trials
115 504th of 2000 higher than 1,494 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia